Summary
Industry
Insights
Sonio, a Paris-based company, leverages artificial intelligence to enhance prenatal screening accuracy and efficiency. Its Software-as-a-Service (SaaS) model allows for easy integration into healthcare workflows. By using AI, Sonio aims to reduce risks associated with traditional ultrasound and manual analysis, where missed or delayed detections can have serious repercussions for both mother and baby. Supported by investors like Bpifrance and Elaia, Sonio is well-positioned to address gaps in the prenatal screening market and set new standards in prenatal healthcare.
Investors
Elaia Series A
OneRagtime Series A
Bpifrance Series A
EIC Accelerator Seed